The global cardiac ablation market is anticipated to grow at a CAGR of 12% during the forecast period. The key factors contributing to the market growth include the growing geriatric population coupled with the rise in cardiovascular diseases and technological advancement in the field of ablation devices. The measures taken by governments and healthcare reforms in the US are driving the growth of the market. Emerging countries such as India, China, and Mexico have the growth opportunities for vendors that involve in manufacturing and distribution of products in cardiac ablation. Factors such as rising adoption of ablation in the treatment of cardiac disorders and increasing market penetration of products are providing growth opportunities in the cardiac ablation industry.  

Other factors that are spurring the growth of the global cardiac ablation market include the rising adoption of minimally invasive surgeries and innovations in catheters and cardiac procedures. Cardiac ablation is a procedure to destroy the tissues in the heart that is responsible for producing abnormal rhythm in the heart. Cardiac ablation is widely used in the treatment of Arrhythmias, Atrial Fibrillation (AF), Wolff-Parkinson-White (WPW) Syndrome, Tachycardia, Atrial Flutter, and others. All these are major applications of cardiac ablation that is augmenting the demand for cardiac ablation procedure in the market. There are various benefits offered by the cardiac ablation procedures such as the low risk of complication, quick recovery and higher success rate.

Segmental Outlook  

The global cardiac ablation market is segmented on the basis of technology and application. Based on technology, the market is segmented into cryoablation, radiofrequency ablation, microwave ablation and ultrasound ablation. The radiofrequency ablation is expected to have a significant share in the market. Further, on the basis of application, the market is bifurcated into cardiac rhythm management and open surgery. Cardiac rhythm management includes cardiac arrhythmia, atrial fibrillation and flutter, and tachycardia. 

Global Cardiac Ablation Market Share by Application, 2018 (%)

Technology Insights: Radiofrequency Ablation to Hold a Prominent Share in the Global Cardiac Ablation Market

Radiofrequency ablation is expected to hold a significant share in the market in 2018. Radiofrequency ablation is a well-established procedure with high safety and efficacy, which results in its increasing adoption. In addition, it is a minimally invasive procedure and possesses a low risk profile. The increasing trend towards minimally invasive surgical procedures is one of the major factors contributing to the segmental growth of the market. Furthermore, radiofrequency ablation is technically simple to perform, which makes it a preferable choice; and thereby, contributes to the growth of the market.

Regional Outlook 

Geographically, the market is analyzed on the basis of four major regions; North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to be a dominant player over the forecast period with the US being the major contributor. The market growth is attributed to high prevalence of cardiovascular diseases in the region. Additionally, availability of a high-quality healthcare system and high healthcare spending is also estimated to boost the growth of the North American cardiac ablation market. Moreover, Asia-Pacific is expected to grow at a considerable rate during the forecast period due to increasing healthcare expenditure, rising disposable income, and growing geriatric population coupled with increasing incidences of heart-related disorders.

Global Cardiac Ablation Market Growth by Region 2019-2025

Asia-Pacific will Strengthen with the Fastest Growth Rate in the Market 

The Asia-Pacific market is full of opportunities and considered to be the most emerging market due to a huge population pool of coronary heart diseases, stroke, and other heart diseases. The Asia-Pacific region is growing at a significant rate due to various factors such as rising healthcare spending, improving healthcare infrastructure and rising standards of living. China, India, Japan, and South Korea are the key regions contributing significantly due to the increasing demand for cardiac ablation surgeries and devices in the region. The adoption of innovative cardiac ablation surgeries and robotic automation is further driving the Asia-Pacific cardiac ablation market. The healthcare system in the Asia-Pacific region is improving significantly and is expected to contribute to the regional growth of the market. 

Market Players Outlook

Some of the key players of the market include Medtronic PLC, Koninklijke Phillips NV, Boston Scientific Corp., Abbott Laboratories Inc., Johnson & Johnson Services, Inc., Stryker Corp., and others. These market players are focusing on product launch, R&D, product development and technological advancement to ensure better success rates and curb complications during procedures.

Recent Developments

• In May 2019, Royal Philips established a collaboration with Medtronic PLC for further advancing the treatment of paroxysmal atrial fibrillation (PAF). Through the deal, Medtronic will facilitate sales of products on behalf of Philips for providing an innovative, integrated image guidance solution for cryoablation procedures. Philips will bring the novel KODEX-EPD cardiac imaging and navigation system with cryoablation specific features to the market for helping electrophysiologists to perform cryoablation procedures with reduced need for X-ray imaging.

• In January 2019, Abbott Laboratories Inc. received the FDA approval for its TactiCath Contact Force Ablation Catheter, Sensor Enabled, for the treatment of atrial fibrillation (AFib). TactiCath is developed for providing precise images of the heart along with real-time electrical activity information.

The Report Covers

• Market value data analysis of 2018 and forecast to 2025.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global cardiac ablation market. Based on the availability of data, information related to products, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.